Naturalistic light exposure patterns in relation to medication status, mood symptoms, and chronotype.
Level 4 - case-series / case-control
Cross-sectional observational study comparing SSRI users and non-medicated controls
PubMed 41776291 · doi:10.1038/s44323-025-00062-0
What was done
Researchers monitored naturalistic light exposure for at least one week using wearable sensors measuring objective melanopic equivalent daylight illuminance (melanopic EDI) in 76 participants (38 taking selective serotonin reuptake inhibitors [SSRIs] and 38 unmedicated controls without psychiatric history). Participants also completed questionnaires evaluating mood symptoms (DASS-21) and chronotype (Morningness-Eveningness Questionnaire, MEQ).
What was found
Overall light exposure did not differ between SSRI users and controls. Accounting for group status, higher morning light exposure was associated with lower depressive and stress symptoms, and greater time spent above 50 melanopic EDI was associated with fewer depressive symptoms. A morning chronotype was linked to higher morning and daytime melanopic EDI, increased time in bright light (>50 and >250 melanopic EDI), and differences in light regularity. The abstract reports no numerical effect sizes, confidence intervals, or p-values.
Why it matters
This study provides objective wearable data showing that the timing and intensity of daily light exposure relate to mood symptoms and chronotype, and that these associations persist independently of SSRI medication status.
Limits
The observational, cross-sectional design cannot establish whether light exposure improves mood or whether individuals with better mood simply spend more time in bright morning light. The sample size was modest (n = 76), and the abstract provides no specific numerical values, effect sizes, or control for potential confounders such as outdoor physical activity, occupational schedules, or sleep duration.